Creative Biolabs-Immuno-oncology

Anti-CD22 (clone I1C1R22-6) SynExpress E1-G-I4-H CD8+ T Cells (CAT#: ITS-1124-CR32)

DatasheetDatasheet
Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1C1R22-6). We employs the Adenovirus (EF1α-GFP-IL-4-HindIII) vector components and the SynExpress system of the introns Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1C1R22-6
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
Adenovirus
Transformation Accuracy
0.89
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving